1. PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer Progression
   Shuo Deng et al, 2022, Cancers CrossRef
2. Advances in Biomedical Functions of Natural Whitening Substances in the Treatment of Skin Pigmentation Diseases
   Fan Liu et al, 2022, Pharmaceutics CrossRef
3. Metabolic and toxicological considerations for phosphoinositide 3-kinase delta inhibitors in the treatment of chronic lymphocytic leukemia
   Magdalena Witkowska et al, 2023, Expert Opinion on Drug Metabolism & Toxicology CrossRef
4. Targeting PI3K/AKT/mTOR Signaling Pathway as a Radiosensitization in Head and Neck Squamous Cell Carcinomas
   Yu-Chieh Su et al, 2022, International Journal of Molecular Sciences CrossRef
5. Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment
   Fabio Raith et al, 2023, International Journal of Molecular Sciences CrossRef
6. Developing PI3K Inhibitors for Respiratory Diseases
   E. Fagone et al, 2022, PI3K and AKT Isoforms in Immunity CrossRef
7. Advances in Immunosuppressive Agents Based on Signal Pathway
   Zhiqing Xu et al, 2022, Frontiers in Pharmacology CrossRef
8. Inhibitors of phosphoinositide 3-kinase (PI3K) and phosphoinositide 3-kinase-related protein kinase family (PIKK)
   Xueqin Huang et al, 2023, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
9. Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy
   Qingfang Li et al, 2022, Molecular Biomedicine CrossRef
10. Role of protein phosphorylation in cell signaling, disease, and the intervention therapy
    Kun Pang et al, 2022, MedComm CrossRef
11. A Drug Screening Reveals Minocycline Hydrochloride as a Therapeutic Option to Prevent Breast Cancer Cells Extravasation across the Blood–Brain Barrier
    Joana Godinho-Pereira et al, 2022, Biomedicines CrossRef
12. Metformin and buparlisib synergistically induce apoptosis of non-small lung cancer (NSCLC) cells via Akt/FoxO3a/Puma axis
    Wang Shanshan et al, 2024, Toxicology in Vitro CrossRef
13. Resistance of prostate cancer to kinase inhibitors
    Palak A. Patel et al, 2024, Therapy Resistance in Prostate Cancer CrossRef